Stay updated with breaking news from Crispr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, today announced its patent CN201380038920.6 was upheld by the CNIPA in response to an invalidation challenge.
High costs and the complexity of administering the drugs may keep them out of reach of patients in need
The future of medicine could lie in gene editing, and researchers at Rensselaer Polytechnic Institute are at the forefront of it.This work inside an RPI lab is
Scientists have found a biological hack to keep French fries golden and tastier, addressing the issue of them turning dark and bitter.
Pigs that have been given genetically engineered immunity to porcine reproductive and respiratory syndrome, a major and costly disease, could be on the market within two years